NYSE:AMRX - Amneal Pharmaceuticals Price Target & Analyst Ratings

-0.47 (-6.40 %)
(As of 06/17/2019 03:17 AM ET)
Today's Range
Now: $6.87
50-Day Range
MA: $9.59
52-Week Range
Now: $6.87
Volume974,818 shs
Average Volume1.04 million shs
Market Capitalization$2.05 billion
P/E Ratio7.23
Dividend YieldN/A

Analyst Ratings

Amneal Pharmaceuticals (NYSE:AMRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for Amneal Pharmaceuticals in the last 12 months. Their average twelve-month price target is $16.30, suggesting that the stock has a possible upside of 137.26%. The high price target for AMRX is $28.00 and the low price target for AMRX is $9.00. There are currently 6 hold ratings, 4 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldHold
Consensus Rating Score: 2.552.362.362.33
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
4 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $16.30$20.00$20.7778$22.1429
Price Target Upside: 137.26% upside83.32% upside44.19% upside35.60% upside

Amneal Pharmaceuticals (NYSE:AMRX) Consensus Price Target History

Price Target History for Amneal Pharmaceuticals (NYSE:AMRX)

Amneal Pharmaceuticals (NYSE:AMRX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/12/2019Cantor FitzgeraldLower Price TargetOverweight$35.00 ➝ $14.00LowView Rating Details
6/11/2019BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$9.00HighView Rating Details
5/21/2019Raymond JamesUpgradeMarket Perform ➝ Strong-Buy$13.00HighView Rating Details
5/10/2019BMO Capital MarketsLower Price TargetMarket Perform$14.00 ➝ $13.00HighView Rating Details
3/19/2019SunTrust BanksInitiated CoverageBuy ➝ Buy$16.00LowView Rating Details
3/8/2019Svb LeerinkDowngradeOutperform ➝ Market Perform$16.00 ➝ $12.00LowView Rating Details
3/8/2019Leerink SwannDowngradeMarket PerformMediumView Rating Details
12/14/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$24.00 ➝ $18.00MediumView Rating Details
9/4/2018Canaccord GenuityReiterated RatingHold$21.00MediumView Rating Details
8/22/2018B. RileyBoost Price TargetBuy ➝ Buy$26.00 ➝ $28.00LowView Rating Details
8/13/2018Royal Bank of CanadaUpgradeSector Perform ➝ OutperformHighView Rating Details
5/18/2018GuggenheimReiterated RatingHoldLowView Rating Details
5/18/2018JPMorgan Chase & Co.Initiated CoverageNeutral$18.00MediumView Rating Details
(Data available from 6/17/2017 forward)
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Featured Article: Outstanding Shares

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel